中国比较医学杂志2017，Vol.27Issue(3)：36-42,7.DOI:10.3969.j.issn.1671-7856.2017.03.007
自拟葛花解酒涤脂汤对酒精性脂肪肝小鼠肝脏脂肪沉积及PXR表达的影响
Effect of Gehua Jiejue Dizhi decoction on the liver fatty deposition and expression of PXR in themousealcoholic fatty liver
摘要
Abstract
Objective To explore the effect of a herbalcompound Gehua Jiejue Dizhi Decoction (GJDD) on the liver fat deposition and the expression of PXR, and the mRNA and protein expression of its target genes CYP3A11 and CYP3A25in the liver tissues of mouse models of alcoholic fatty liver.Methods Twenty-nine healthy male C57BL/6J mice were randomly divided into control group (n=5), model group (n=8), high dose GJDD group (n=8)and low dose GJDD group (n=8).The mouse model of alcoholic fatty liver was prepared according to the National Institute on Alcohol Abuse and Alcoholism (NIAAA) method.Then, the mice were treated with the high dose and low dose GJDD for 9 days.Serum glutamic-pyruvic transaminase (AST) and aspartate aminotransferase (AST) were detected by enzyme-linked immunosorbent assay (ELISA).Liver fat deposition was detected by oil red O staining.Real-time RT-PCR and immunohistochemistry were performed to examine the expressions of PXR, CYP3A11 and CYP3A25.Results Compared with the model group, the liver fat deposition in the intervention groups was significantly reduced in a dose-dependent manner, with a significant increase of the expression of PXR and CYP3A25 (P < 0.01).The serum ALT level was significantly reduced in the model group (P < 0.01), while the transcriptional levels of CYP3A11 mRNA in the groups were similar (P ≥ 0.05).Conclusions Gehua Jiejue Dizhi Decoction has obvious therapeutic effect on the AFLD in mice, which may be related to the activation of PXR and its target genes CYP3A25.关键词
酒精性脂肪肝/葛花解酒涤脂汤/孕烷受体/CYP3A11/CYP3A25Key words
Alcoholic fatty liver/Gehua Jiejue Dizhi Decoction/PXR/CYP3A11/CYP3A25分类
医药卫生引用本文复制引用
易旭,游绍伟,龙毅,王硕石,陆道敏..自拟葛花解酒涤脂汤对酒精性脂肪肝小鼠肝脏脂肪沉积及PXR表达的影响[J].中国比较医学杂志,2017,27(3):36-42,7.基金项目
贵州省中医药管理局中医药、民族医药科学技术课题研究 (No.Qzyy-2-14-008). （No.Qzyy-2-14-008）
